Since the discovery of the mutated CFTR gene in cystic fibrosis patients, scientists have been working on the development of gene therapy for this patient group. Recently, a gene therapy phase II clinical trial with 116 participants in the UK resulted in the halt of disease progression, although there was little effect. The article was published in The Lancet. Continue reading
Showing articles tagged with 'Cystic Fibrosis'
- Platelet transfusion after stroke not beneficial for patients using antiplatelet drugs
- Mindfulness can help prevent depression relapse
- Swift blood transfusion after trauma lowers risk of death
- ‘Milestone’ in cocaine dependence treatment: dexamfetamine effective and safe
- Stress response after childhood trauma measurable in DNA
- Antibiotic resistance growing global problem for children with urinary tract infection
- Venous thromboembolism after radical cystectomy associated with lower survival of bladder cancer
- Microbirthing: a good or a bad idea?
- Researchers predict IVF failure using gene expression profiling
- Recovery sleep could compensate elevated risk of diabetes
- Preseasonal treatment with omalizumab prevents fall asthma exacerbations
- Obese patients: more mental health conditions than expected
Most popular tags
Join our newsletter
And stay updated throughout.